See more : Voltas Limited (VOLTAS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Recovery International Co.,Ltd. (9214.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Recovery International Co.,Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- Great-West Lifeco Inc (GWO-PM.TO) Income Statement Analysis – Financial Results
- InnovAge Holding Corp. (INNV) Income Statement Analysis – Financial Results
- Randstad N.V. (RAND.AS) Income Statement Analysis – Financial Results
- Asian American Medical Group Limited (AJJ.AX) Income Statement Analysis – Financial Results
- Henderson Investment Limited (0097.HK) Income Statement Analysis – Financial Results
Recovery International Co.,Ltd. (9214.T)
About Recovery International Co.,Ltd.
Recovery International Co.,Ltd. offers home-visit nursing and rehabilitation in-home nursing care services in Japan. It provides home-visit nursing care for people with illness or disability patients; physical, occupational therapists, and speech language pathologists services to maintain and restore mental and physical functions; and home-visit massage services for physically handicapped patients. The company was incorporated in 2013 and is based in Shinjuku-Ku, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1.61B | 1.39B | 1.12B | 766.64M | 699.00M |
Cost of Revenue | 957.67M | 838.75M | 666.76M | 474.32M | 457.00M |
Gross Profit | 647.34M | 546.66M | 456.07M | 292.32M | 242.00M |
Gross Profit Ratio | 40.33% | 39.46% | 40.62% | 38.13% | 34.62% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 49.00M | 41.00M | 36.00M | 0.00 | 0.00 |
Selling & Marketing | 440.00M | 341.00M | 270.00M | 0.00 | 0.00 |
SG&A | 489.73M | 382.00M | 306.00M | 274.00M | 222.00M |
Other Expenses | 8.00M | -5.08M | 4.33M | 5.20M | 0.00 |
Operating Expenses | 496.86M | 391.80M | 310.25M | 274.84M | 230.00M |
Cost & Expenses | 1.45B | 1.23B | 977.01M | 749.16M | 687.00M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 376.00K | 762.00K | 1.17M | 1.96M | 1.70M |
Depreciation & Amortization | 7.12M | 9.85M | 4.30M | 1.85M | -20.00M |
EBITDA | 161.06M | 159.61M | 154.45M | 23.93M | 0.00 |
EBITDA Ratio | 10.03% | 11.52% | 13.76% | 3.20% | -0.72% |
Operating Income | 150.49M | 154.86M | 145.82M | 17.47M | 20.00M |
Operating Income Ratio | 9.38% | 11.18% | 12.99% | 2.28% | 2.86% |
Total Other Income/Expenses | 3.07M | -5.86M | 3.16M | 2.64M | -7.77M |
Income Before Tax | 153.56M | 149.00M | 148.97M | 20.12M | 11.00M |
Income Before Tax Ratio | 9.57% | 10.75% | 13.27% | 2.62% | 1.57% |
Income Tax Expense | 43.42M | 40.70M | 48.11M | -7.42M | 2.00M |
Net Income | 110.14M | 108.30M | 100.86M | 27.54M | 13.00M |
Net Income Ratio | 6.86% | 7.82% | 8.98% | 3.59% | 1.86% |
EPS | 77.90 | 78.36 | 91.59 | 25.01 | 9.38 |
EPS Diluted | 76.31 | 75.61 | 91.59 | 19.87 | 9.38 |
Weighted Avg Shares Out | 1.41M | 1.38M | 1.10M | 1.10M | 1.39M |
Weighted Avg Shares Out (Dil) | 1.44M | 1.43M | 1.10M | 1.39M | 1.39M |
Source: https://incomestatements.info
Category: Stock Reports